Shared genetics between breast cancer and predisposing diseases identifies novel breast cancer treatment candidates
Abstract Background Current effective breast cancer treatment options have severe side effects, highlighting a need for new therapies. Drug repurposing can accelerate improvements to care, as FDA-approved drugs have known safety and pharmacological profiles. Some drugs for other conditions, such as...
Saved in:
| Main Authors: | Panagiotis N. Lalagkas, Rachel D. Melamed |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-11-01
|
| Series: | Human Genomics |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40246-024-00688-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The shared genetic landscape of polycystic ovary syndrome and breast cancer: convergence on ER + breast cancer but not ER- breast cancer
by: Kaixin Bi, et al.
Published: (2024-11-01) -
MOLECULAR-GENETIC «PORTRAIT» OF BREAST CANCER
by: S. A. Laptiev, et al.
Published: (2017-06-01) -
Radiation-induced morphea of the breast – characterization and treatment of fibroblast dysfunction with repurposed mesalazine
by: Stephan R. Künzel, et al.
Published: (2024-10-01) -
Effect of Some predisposing factors on Vulvovaginal Candidiasis
by: Baghdad Science Journal
Published: (2010-09-01) -
Evaluation of antibiotics as potential antiproliferative agent against triple-negative breast cancer: a cell-based repurposing study
by: Khaled Mahmoud, et al.
Published: (2025-01-01)